News and Events

12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release

10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here

10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies

LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie restriction
1/25/2009 Link to story and video

LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS ONE

Welcome to LifeGen Technologies
Aging - Genomics - Nutrition

LifeGen Technologies is a genomics company that focuses on gene expression profiling as it relates to the aging process.

Our mission at LifeGen Technologies is to discover the genetic basis of the aging process with the goal of increasing the healthy life span of humans and animals.

LifeGen Technologies, LLC is a Madison, Wisconsin-based genomics company that is focusing on gene expression analysis as it relates to the aging process of humans and animals. LifeGen's pioneering research has resulted in several pending patents, and on-going research is expected to yield additional, important intellectual property. Accordingly, LifeGen Technologies is strategically positioned to serve as a valuable partner to other companies involved in drug development and in animal and human nutraceuticals.


Caloric restriction delays disease onset and mortality in rhesus monkeys (Science. 2009)

Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants (Aging Cell. 2009)

Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart
(Experimental Gerontology 2008)

Separator

Copyright © 2009, LifeGen Technologies LLC    Site Map  |  Legal  |  Contact  |  Websults